There is a shortage of methylphenidate, the generic name for Ritalin, in the United States according to the American Society of Health-System Pharmacists
, though it is not listed in the FDA's drug shortage database.
The FDA is working with manufacturers to increase supply in response to the increased demand.
See more results on Neeva
Summaries from the best pages on the web
The FDA is continuing to monitor the supply chain due to the COVID-19 outbreak and is working closely with manufacturers to increase supply in response to the increased demand. Industry can notify the FDA Drug Shortage Staff via CDER Direct NextGen Portal or the FDA Drug Shortages Mobile App, and can also submit a report to the FDA on the Drug Shortages Task Force Public Meeting. The FDA also provides resources such as a webcast, director's corner podcasts, and a mobile app to help reduce the impact of drug shortages.
Drug Shortages | FDA - U.S. Food and Drug Administration
Drug shortages can have a significant impact on patient care and public health. Drugs in short supply often include sterile injectables and potentially life-saving oncology (cancer) treatments. Besides the lack…
Current Drug Shortages List - Drugs.com
FDA Announces Shortage of Adderall | FDA FDA Announces Shortage of Adderall On October 12, 2022, FDA posted a shortage of the immediate release formulation of amphetamine mixed salts,...
FDA Announces Shortage of Adderall | FDA